Literature DB >> 19444913

Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort.

Eva Erber1, Unhee Lim, Gertraud Maskarinec, Laurence N Kolonel.   

Abstract

Severe immune dysfunction is an established risk factor of lymphoma, but the role of moderate alterations of immunity is not clear and prospective investigations are needed. We examined several immune-related disorders and medications in relation to non-Hodgkin lymphoma (NHL) in the Multiethnic Cohort. Over 215,000 subjects of African American, Caucasian, Japanese American, Latino and Native Hawaiian ancestry aged 45-75 years completed a questionnaire, including information on medical history, in 1993-1996. After exclusions, we performed Cox regression among 193,050 cohort members including 939 incident NHL cases while adjusting for sex, age, ethnicity, education, body mass index and alcohol intake. Self-reported diabetes was not associated with NHL overall, but was positively associated with risk among Japanese Americans [hazard ratio (HR) = 1.55; 95% confidence interval (CI): 1.10-2.17]. Participants with a history of blood transfusion were at increased risk with HR = 1.39 (95% CI: 1.06-1.84) in men and HR = 1.22 (95% CI: 0.94-1.58) in women, especially for the diffuse large B-cell lymphoma subtype. History of asthma or other allergies was associated with elevated risk only among Latinos (HR = 1.46; 95% CI: 1.07-2.00) who also showed a significant relation between current use of antihistamines and NHL (HR = 1.80; 95% CI: 1.09-2.97). Use of nonsteroidal anti-inflammatory drugs was not associated with NHL. Our findings from this large prospective study support a moderate risk for NHL related to blood transfusions, current long-term antihistamine use and diabetes, but the associations were limited to certain ethnic groups and require further replications. 2009 UICC

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444913      PMCID: PMC2734966          DOI: 10.1002/ijc.24456

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  46 in total

Review 1.  Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.

Authors:  Karin Ekström Smedby; Eva Baecklund; Johan Askling
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

Review 2.  Epidemiology and etiology of non-Hodgkin lymphoma--a review.

Authors:  Karin Ekström-Smedby
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

Review 3.  Altered immunity as a risk factor for non-Hodgkin lymphoma.

Authors:  Andrew E Grulich; Claire M Vajdic; Wendy Cozen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03-02       Impact factor: 4.254

Review 4.  The non-Hodgkin lymphomas: a review of the epidemiologic literature.

Authors:  Dominik D Alexander; Pamela J Mink; Hans-Olov Adami; Ellen T Chang; Philip Cole; Jack S Mandel; Dimitrios Trichopoulos
Journal:  Int J Cancer       Date:  2007       Impact factor: 7.396

Review 5.  The risk of lymphoma development in autoimmune diseases: a meta-analysis.

Authors:  Elias Zintzaras; Michael Voulgarelis; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2005-11-14

6.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

Authors:  Lindsay M Morton; Jennifer J Turner; James R Cerhan; Martha S Linet; Patrick A Treseler; Christina A Clarke; Andrew Jack; Wendy Cozen; Marc Maynadié; John J Spinelli; Adele Seniori Costantini; Thomas Rüdiger; Aldo Scarpa; Tongzhang Zheng; Dennis D Weisenburger
Journal:  Blood       Date:  2007-03-27       Impact factor: 22.113

7.  Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.

Authors:  Nathaniel Rothman; Christine F Skibola; Sophia S Wang; Gareth Morgan; Qing Lan; Martyn T Smith; John J Spinelli; Eleanor Willett; Silvia De Sanjose; Pierluigi Cocco; Sonja I Berndt; Paul Brennan; Angela Brooks-Wilson; Sholom Wacholder; Nikolaus Becker; Patricia Hartge; Tongzhang Zheng; Eve Roman; Elizabeth A Holly; Paolo Boffetta; Bruce Armstrong; Wendy Cozen; Martha Linet; F Xavier Bosch; Maria Grazia Ennas; Theodore R Holford; Richard P Gallagher; Sara Rollinson; Paige M Bracci; James R Cerhan; Denise Whitby; Patrick S Moore; Brian Leaderer; Agnes Lai; Charlotte Spink; Scott Davis; Ramon Bosch; Aldo Scarpa; Yawei Zhang; Richard K Severson; Meredith Yeager; Stephen Chanock; Alexandra Nieters
Journal:  Lancet Oncol       Date:  2006-01       Impact factor: 41.316

8.  Use of nonsteroidal antiinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study.

Authors:  E Dawn Flick; K Arnold Chan; Paige M Bracci; Elizabeth A Holly
Journal:  Am J Epidemiol       Date:  2006-07-13       Impact factor: 4.897

9.  Risk of non-Hodgkin lymphoma and use of non-steroidal anti-inflammatory drugs.

Authors:  Yuqing Zhang; Patricia F Coogan; Julie R Palmer; Brian L Strom; Lynn Rosenberg
Journal:  Cancer Detect Prev       Date:  2006-02-21

10.  The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk.

Authors:  W Cozen; J R Cerhan; O Martinez-Maza; M H Ward; M Linet; J S Colt; S Davis; R K Severson; P Hartge; L Bernstein
Journal:  Cancer Causes Control       Date:  2007-06-22       Impact factor: 2.506

View more
  20 in total

1.  Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States.

Authors:  Jill Koshiol; Tram Kim Lam; Gloria Gridley; David Check; Linda Morris Brown; Ola Landgren
Journal:  J Clin Oncol       Date:  2010-12-20       Impact factor: 44.544

2.  Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults.

Authors:  Cindy M Chang; Joan L Warren; Eric A Engels
Journal:  Cancer       Date:  2012-05-30       Impact factor: 6.860

3.  Antihistamine use and immunoglobulin E levels in glioma risk and prognosis.

Authors:  E Susan Amirian; Deborah Marquez-Do; Melissa L Bondy; Michael E Scheurer
Journal:  Cancer Epidemiol       Date:  2013-08-30       Impact factor: 2.984

4.  Mortality in Patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.

Authors:  Stephanie L McManimen; Andrew R Devendorf; Abigail A Brown; Billie C Moore; James H Moore; Leonard A Jason
Journal:  Fatigue       Date:  2016-10-12

5.  Farm characteristics, allergy symptoms, and risk of non-hodgkin lymphoid neoplasms in the agricultural health study.

Authors:  Jonathan N Hofmann; Jane A Hoppin; Charles F Lynch; Jill A Poole; Mark P Purdue; Aaron Blair; Michael C Alavanja; Laura E Beane Freeman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-12       Impact factor: 4.254

6.  Erythrocyte membrane fatty acid composition, serum lipids, and non-Hodgkin's lymphoma risk in a nested case-control study: the multiethnic cohort.

Authors:  Yukiko Morimoto; Shannon M Conroy; Nicholas J Ollberding; Susanne M Henning; Adrian A Franke; Lynne R Wilkens; Marc T Goodman; Brenda Y Hernandez; Loïc Le Marchand; Brian E Henderson; Laurence N Kolonel; Gertraud Maskarinec
Journal:  Cancer Causes Control       Date:  2012-08-21       Impact factor: 2.506

7.  Allergic diseases and risk of hematopoietic malignancies in a cohort of postmenopausal women: a report from the Iowa Women's Health Study.

Authors:  Amy M Linabery; Anna E Prizment; Kristin E Anderson; James R Cerhan; Jenny N Poynter; Julie A Ross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-24       Impact factor: 4.254

8.  Risk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use.

Authors:  Sarah J Lowry; Jessica Chubak; Oliver W Press; Barbara McKnight; Noel S Weiss
Journal:  Ann Epidemiol       Date:  2013-06       Impact factor: 3.797

9.  Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Martha S Linet; Claire M Vajdic; Lindsay M Morton; Anneclaire J de Roos; Christine F Skibola; Paolo Boffetta; James R Cerhan; Christopher R Flowers; Silvia de Sanjosé; Alain Monnereau; Pierluigi Cocco; Jennifer L Kelly; Alexandra G Smith; Dennis D Weisenburger; Christina A Clarke; Aaron Blair; Leslie Bernstein; Tongzhang Zheng; Lucia Miligi; Jacqueline Clavel; Yolanda Benavente; Brian C H Chiu
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

10.  Associations between allergies and risk of hematologic malignancies: results from the VITamins and lifestyle cohort study.

Authors:  Mazyar Shadman; Emily White; Anneclaire J De Roos; Roland B Walter
Journal:  Am J Hematol       Date:  2013-12       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.